News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,926 Results
Type
Article (44880)
Company Profile (356)
Press Release (673690)
Section
Business (212062)
Career Advice (2235)
Deals (36497)
Drug Delivery (97)
Drug Development (82614)
Employer Resources (173)
FDA (16739)
Job Trends (15374)
News (357001)
Policy (33632)
Tag
Academia (2732)
Alliances (52346)
Alzheimer's disease (1290)
Approvals (16667)
Artificial intelligence (164)
Bankruptcy (359)
Best Places to Work (11896)
Biotechnology (253)
Breast cancer (180)
Cancer (1339)
Cardiovascular disease (110)
Career advice (1866)
Cell therapy (286)
Clinical research (65734)
Collaboration (464)
Compensation (247)
COVID-19 (2668)
C-suite (113)
Data (1374)
Diabetes (166)
Diagnostics (6451)
Earnings (86501)
Employer resources (152)
Events (114709)
Executive appointments (372)
FDA (17376)
Funding (424)
Gene therapy (207)
GLP-1 (626)
Government (4490)
Healthcare (19487)
Infectious disease (2760)
Inflammatory bowel disease (117)
Interviews (359)
IPO (16689)
Job creations (3880)
Job search strategy (1596)
Layoffs (437)
Legal (8153)
Lung cancer (190)
Manufacturing (204)
Medical device (13960)
Medtech (13965)
Mergers & acquisitions (19936)
Metabolic disorders (448)
Neuroscience (1609)
NextGen Class of 2024 (6896)
Non-profit (4639)
Northern California (1652)
Obesity (258)
Opinion (211)
Patents (120)
People (58707)
Phase I (20587)
Phase II (28912)
Phase III (21526)
Pipeline (506)
Postmarket research (2606)
Preclinical (8819)
Radiopharmaceuticals (255)
Rare diseases (256)
Real estate (6266)
Regulatory (22383)
Research institute (2484)
Resumes & cover letters (375)
Southern California (1441)
Startups (3865)
United States (15087)
Vaccines (602)
Weight loss (186)
Date
Today (112)
Last 7 days (689)
Last 30 days (2977)
Last 365 days (36457)
2024 (35402)
2023 (41231)
2022 (52512)
2021 (57119)
2020 (55788)
2019 (48624)
2018 (36624)
2017 (33755)
2016 (33374)
2015 (39536)
2014 (33112)
2013 (28161)
2012 (30431)
2011 (31029)
2010 (28952)
Location
Africa (793)
Arizona (203)
Asia (40183)
Australia (6697)
California (3743)
Canada (1407)
China (295)
Colorado (173)
Connecticut (176)
Europe (88048)
Florida (514)
Georgia (138)
Illinois (391)
Indiana (222)
Kansas (99)
Maryland (626)
Massachusetts (2959)
Michigan (184)
Minnesota (293)
New Jersey (1080)
New York (1058)
North Carolina (774)
Northern California (1652)
Ohio (146)
Pennsylvania (910)
South America (1184)
Southern California (1441)
Texas (540)
Utah (110)
Washington State (402)
718,926 Results for "alr technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM
ALR Technologies SG Ltd., the diabetes management company, announces plans to launch the GluCurve Pet CGM in Canada during Q3 2023 with a direct to veterinarian clinic sales model through GluCurve.ca.
August 7, 2023
·
5 min read
ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
ALR Technologies SG Ltd. announces the patent application titled Method and System of Monitoring a Diabetes Treatment Plan has been granted in Singapore and has received notice of allowance in the United States.
September 28, 2023
·
5 min read
ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs
ALR Technologies SG Ltd., the diabetes management company, announces the issuance of a purchase order for the first shipment of second generation CGM hardware used in the GluCurve Pet CGM.
June 1, 2023
·
4 min read
ALR Technologies Announces Update to Singapore Migration Merger and GluCurve Pet CGM Commercialization
ALR Technologies Inc., the diabetes management company, is pleased to announce an update with respect to its migration to Singapore.
September 30, 2022
·
11 min read
Deals
ALR Technologies Announces Reincorporation Merger
ALR Technologies Inc. (“ALRT USA”) (OTCQB: ALRT), the diabetes management company, today announces that further to its release on June 1, 2021, ALRT USA has entered into an Agreement and Plan of Merger and Reorganization.
May 20, 2022
·
6 min read
ALR Technologies Announces Update on the GluCurve Pet CGM Distribution and Commercialization
ALR Technologies SG Pte. Ltd, the diabetes management company, announces a distribution agreement with a global leader in animal health is now anticipated to be complete in September.
August 29, 2022
·
6 min read
Business
ALR Technologies Inc. Moves to Singapore
ALR Technologies Inc. announced that it is taking steps to redomicile the Company to Singapore.
June 1, 2021
·
4 min read
Business
GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.
June 20, 2024
·
2 min read
ALR Technologies Announces Sales Guidance for Q4 2022, Q1 2023, and Completion of the GluCurve Pet CGM Manufacturing Agreement
ALR Technologies SG Ltd., the diabetes management company, announced the completion of a long-term manufacturing and supply agreement with Infinovo Medical Co. Ltd for the Continuous Glucose Monitor hardware used in the GluCurve Pet CGM.
December 27, 2022
·
4 min read
UPDATE: ALR Technologies Announces Sales Guidance for Q4 2022, Q1 2023, and Completion of the GluCurve Pet CGM Manufacturing Agreement
ALR Technologies SG Ltd., the diabetes management company, announced the completion of a long-term manufacturing and supply agreement with Infinovo Medical Co. Ltd for the Continuous Glucose Monitor hardware used in the GluCurve Pet CGM.
December 29, 2022
·
4 min read
1 of 71,893
Next
